July 2020 in “International Journal of Research” This review examines the development of cardiovascular risk factors related to testosterone levels in PCOS women and reports no new clinical results.
July 2026 in “Science Progress” This review reports significant improvements in hidradenitis suppurativa symptoms and comorbid conditions with GLP-1-receptor-agonists, suggesting potential as a multimodal treatment strategy.
In this case report, a 23-year-old man experienced dizziness, blurred vision, malaise, and fatigue after excessive use of topical minoxidil for three days, with symptoms resolving once minoxidil was discontinued.
October 2015 in “Elsevier eBooks” Minoxidil is effective for hair growth and safe for long-term use.
November 2024 in “International Society of Hair Restoration Surgery” This study investigated adverse events from low-dose systemic minoxidil in an older population with hair loss and found that 19% experienced mainly facial and body hypertrichosis, managed with interventions like dose reduction and diuretics; no serious adverse events occurred.
